Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-12

Clinical Trial Update: Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease [NA]

View source ↗

Summary

A preliminary clinical study is evaluating whether L-ornithine influences the efficacy of ustekinumab in Crohn's disease. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-ornithine (L-ornithine)
  • Stelara (ustekinumab)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Mild to Severe Crohns Disease | NA | Status: RECRUITING